Home
Live Updates
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 : comparemela.com
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
First analysis from ASCEND-2 confirms high detection rates and specificity achieved with multi-biomarker approach in most aggressive cancers and those with no standard-of-care screening test1
...
Related Keywords
United States ,
San Diego ,
California ,
American ,
Tom Beer ,
Exchange Commission ,
Sciences Corp ,
Drug Administration ,
Sciences On Linkedin ,
American Cancer Society ,
Genomic Health Inc ,
Nasdaq ,
Sciences Corporation ,
Facebook ,
American Association For Cancer Research ,
Exact Sciences ,
American Association ,
Cancer Research ,
Annual Meeting ,
Chief Medical Officer ,
Multi Cancer Early Detection ,
Ascertaining Serial Cancer ,
Enable New Diagnostic ,
Exact Science ,
Early Through Elective ,
Genomic Health ,
Risk Factors ,
Annual Report ,
Quarterly Reports ,
Markets ,
comparemela.com © 2020. All Rights Reserved.